10 Results for "

tetrahydroisoquinoline compound

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "tetrahydroisoquinoline compound" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-W705106
CAS No.: 3422-42-2
Synonyms: (-)-(S)-Coclaurine hydrochloride; L-Coclaurine hydrochloride
(-)-Coclaurine hydrochloride (compound I) is a class of tetrahydroisoquinoline alkaloids that can be isolated from Sarcopetalum harveyanum. (-)-Coclaurine hydrochloride is a nicotinic acetylcholine receptor (nAChRs) antagonist .
loading...
    loading...
Cat. No.: HY-148480
CAS No.: 2728780-74-1
Research Areas:  

Cardiovascular Disease

Nrf2 activator-6, a tetrahydroisoquinoline compound, is a Nrf2 activator. Nrf2 activator-6 has an IC50 of 5 nM for inhibiting the Kelch domain-Nrf2 interaction (WO2021214470A1; Example 4) .
loading...
    loading...
Cat. No.: HY-N0137
CAS No.: 6429-04-5
Research Areas:  

Neurological Disease

Tetrahydropapaverine hydrochloride is a tetrahydroisoquinoline (TIQ) compound with inhibitory effects on tryptophan hydroxylase (TPH) (IC50 = 5.7 μM). Tetrahydropapaverine hydrochloride decreases intracellular serotonin content in murine mastocytoma P815 cells, with an IC50 value of 6.2 μM. Tetrahydropapaverine hydrochloride can be used for studies on potential neurotoxicity in monoaminergic neurons .
loading...
    loading...
Cat. No.: HY-138295
CAS No.: 2578876-75-0
Purity:  99.92%
Target:  

Ras

Research Areas:  

Cancer

KRAS inhibitor-10 selectively and effectively inhibit RAS proteins, and particularly KRAS proteins. KRAS inhibitor-10 is an orally active anti-cancer agent and can be used for cancer research, such as pancreatic cancer, breast cancer, multiple myeloma, leukemia and lung cancer. KRAS inhibitor-10 is a tetrahydroisoquinoline compound (compound 11) extracted from patent WO2021005165 A1 .
loading...
    loading...
Cat. No.: HY-60308A
CAS No.: 57196-62-0
Target:  

Drug Intermediate

Research Areas:  

Others

6-Methoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride is a drug intermediate for synthesis of various active compounds.
loading...
    loading...
Cat. No.: HY-42318
CAS No.: 1870821-29-6
Target:  

Drug Intermediate

Research Areas:  

Others

(S)-4-(3-Bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline is a drug intermediate for synthesis of various active compounds.
loading...
    loading...
Cat. No.: HY-113969
CAS No.: 61563-24-4
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline (compound 11), a tetrahydroisoquinoline (THIQ) derivative, is a selective phenylethanolamine N-methyltransferase (PNMT) inhibitor with a Ki value of 0.3 μM. 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline can be used in research on psychiatric disorders related to Alzheimer's disease and Parkinson's disease .
loading...
    loading...
Cat. No.: HY-156079
CAS No.: 1071049-42-7
Target:  

Monoamine Oxidase

Research Areas:  

Neurological Disease

Antidepressant agent 5 (Compound 3i) is a 7-substituted tetrahydroisoquinolines derivatives. Antidepressant agent 5 exhibits almost equal antidepressant activity compared with magnoflorine. ntidepressant agent 5 can be used for depressive disorder research .
loading...
    loading...
Cat. No.: HY-W045121
CAS No.: 933752-32-0
1,2,3,4-Tetrahydroisoquinoline-6-carboxylic acid is a kind of biological materials or organic compounds that are widely used in life science research.
loading...
    loading...
Cat. No.: HY-164726
CAS No.: 96719-63-0
Target:  

Estrogen Receptor/ERR

Research Areas:  

Others

Estrogen receptor modulator 11 (Compound 27) is a tetrahydroisoquinoline derivative. Estrogen receptor modulator 11 has a certain affinity for estrogen receptors (ER), with IC50 values of 285 nM and 421 nM for ERα and ERβ, respectively. Estrogen receptor modulator 11 lacks antagonist activity in the MCF-7 cellular assay .
loading...
    loading...